Providing pharmaceutical companies with compliant, commercially viable oral and injectable generic drug consistency evaluation, generic drug development and registration, connected to high-quality bioequivalence pilot and pivotal studies, as well as CMA-certified in-house packaging material compatibility studies and GLP safety studies.